Korean Division
Division website: https://www.pathology.or.kr/english/
NUMBER OF MEMBERS
2013 1,043
2014 1,064
2015 1,092
2016 1,126
2017 1,157
2018 1,188
2019 1,218
2020 1,249
2021 1,218
*Updated: March 10, 2022
OFFICERS
President
Nam Hoon Cho, M.D. Yonsei University Severance Hospital
Past President
Chan Choi, M.D. Chonnam National University Hospital
Chairman-Elect
Youn Soo Lee, M.D. Catholic University Seoul St. Mary's Hospital
Secretary-General
Kee-Taek Jang, M.D. Sungkyunkwan University
COUNCILORS
Nam Hoon Cho, M.D. Yonsei University Severance Hospital
Seung-Mo Hong, M.D. Ulsan University
Haeryoung Kim, M.D. Seoul National University
Original VP Report in PDF format
COMMITTEE CHAIRS
Publication Committee
Chankwon Jung, M.D.
Academic Affairs Committee
Ah Won Lee, M.D.
Training Programs Committee
Jihoon Kim, M.D.
Catholic University Seoul St. Mary's Hospital
Catholic University Seoul St. Mary's Hospital
Ulsan University
Training Board Committee
Yoo Duk Choi, M.D. Chonnam National University
Planning Committee
Hye-Seung Han, M.D.
Quality Improvement Committee
Hye-Seung Lee, M.D.
Konkuk University
Seoul National University
International Cooperation Committee
Haeryoung Kim, M.D. Seoul National University
Insurance & Policy Committee
Youn Soo Lee, M.D. Catholic University Seoul St. Mary's Hospital
Treasure Committee
Sun Hee Jang, M.D. Inje University
ACTIVITIES IN 2021
I. The 46th Annual Spring Meeting of the Korean Society of Pathologists and the 74th Meeting of the Korean Division of the International Academy of Pathology
Date: May 13-14, 2021
Location: Virtual congress (www.keymedi.com)
Slogan: Pathology: Eyes Beyond Human Limit
Scientific content
I. Short Course: Pulmonary pathology for general pathologists
i. Diagnostic approach for poorly differentiated carcinoma (Si Hyung Chang, Soonchunhyang University)
ii. Reporting for resection specimen (Ji Yoon Jung, Kyungpook National University)
iii. PD-L1 interpretation for immunotherapy (Sun Hee Jang, Inje University)
iv. IHC and CDx for targeted therapy (Hyo Sup Shim, Yonsei University)
v. Benign tumors, pre-invasive lesions, and cancer-mimickers (Dong Hoon Shin, Pusan National University)
II. Keynote Lectures
A. Emerging role of deep transfer learning in digital pathology (Yoo Chae Jung, KAIST)
B. QuPath: making computation pathology accessible to all with open software (Peter Bankhead, University of Edinburgh)
C. Uterine mesenchymal tumors that mimic leiomyomas (Joseph Rabban, University of
California, San Francisco)
III. Symposiums
A. KSP-KIGTE Joint Education Symposium
i. The quality evaluation system and basic guidelines (Wanseop Kim, Konkuk University)
ii. Laboratory general (Hye Seung Lee, Seoul National University)
iii. Molecular genetics (Jae Kyung Won, Seoul National University)
iv. NGS (Jeongmo Bae, Seoul National University)
v. Cytogenetics (Taejung Kim, Catholic University)
B. Symposium: My interesting case: brief report and review
i. Invasive stratified mucin-producing carcinoma: a distinct entity of HPV-associated endocervical adenocarcinoma (Eunhyang Park, Yonsei University)
ii. A case of segmental membranous nephropathy (Minsun Jung, Yonsei University)
iii. Leukemic infiltration of AML in an HCC survivor: diagnosed by autopsy (Moon Young Kim, Sungkyunkwan University)
iv. An interesting case: sarcoma with BCOR genetic alterations (Binnari Kim, Ulsan University)
v. Autosomal recessive polycystic kidney diseases: an autopsy of a 2-day-old neonate (Soojin Park, Sungkyunkwan University)
C. Symposium: The current status of digital pathology and its future
i. Panel 1: Samsung Medical Center
ii. Panel 2: Seoul National University Hospital
iii. Panel 3: Seoul St. Mary’s Hospital
iv. Panel 4: Severance Hospital
v. Panel 5: Asan Medical Center
D. Symposium: The current status of companion diagnostics and its future
i. An introduction to CDx (Yeoun Eun Sung, Catholic University)
ii. The current status of CDx in Korea (Konkuk Lee, National Cancer Center)
iii. Rules and regulations of CDx (Young Wook Ahn, Ministry of Food and Drug Safety)
iv. Pathology tests as CDx? (Jeongmo Bae, Seoul National University)
v. Implementing CDx in Korea (Yuna Choi, Sungkyunkwan University)
II. The 73rd Annual Spring Meeting of the Korean Society of Pathologists and the 75th Meeting of the Korean Division of the International Academy of Pathology
Date: October 27-29, 2021
Location: Virtual congress (www.keymedi.com)
Slogan: Pathology: Eyes Beyond Human Limit
Scientific content
I. Short Courses:
A. New WHO classification of the CNS tumors
i. Introduction to new WHO classification of the CNS tumors (Sung Hye Park, Seoul National University)
ii. New WHO classification of adult glioma (Soojeong Nam, Ulsan University)
iii. New WHO classification of pediatric glioma (Jae Kyung Won, Seoul National University)
iv. Update on meningiomas (Youn Soo Lee, Catholic University)
B. Recent update in dermatopathology
i. Inflammatory dermatosis: diagnostic clues (Cheol Lee, Seoul National University)
ii. Melanocytic lesion of acral skin: acral nevus and melanoma (Yoonjin Kwak, Seoul National University)
iii. Diagnostic challenges on small biopsies of atypical squamous epithelial lesions (So Deok Lim, Konkuk University)
iv. Spitz tumor (Soon Auck Hong, Chung Ang University)
v. Digital pathology in dermatopathology (Kee-Taek Jang, Sungkyunkwan University)
II. Keynote Lectures
A. Grasp your own research based on practice! (Nam Hoon Cho, Yonsei University)
B. A pathology odyssey: female genital tract (Kyu Rae Kim, Ulsan University)
C. A guide to digital pathology implementation – current trends and barriers to adoption (David
McClintock, University of Michigan)
D. A pathology odyssey: lung cancer (Jin Haeng Chung, Seoul National University)
III. Symposia
A. The current status and future of digital pathology
B. Quality assurance education session
IV. Basic Education Session: Biopsy interpretation of breast disease
i. Intraductal proliferative lesions (So Yeon Park, Seoul National University)
ii. Invasive carcinoma and its mimickers (Soo Yeon Cho, Sungkyunkwan University)
iii. Papillary lesions (Jee Yeon Kim, Pusan National University)
iv. Fibroepithelial lesions (Han Suk Ryu, Seoul National University)
v. Oral and poster presentations